滑膜肉瘤
溴尿嘧啶
SMARCB1型
肉瘤
医学
癌症研究
内科学
肿瘤科
病理
化学
生物化学
基因
转录因子
乙酰化
染色质重塑
作者
J. Andrew Livingston,Jean‐Yves Blay,Jonathan C. Trent,Claudia Valverde,Mark Agulnik,Mrinal M. Gounder,Axel Le Cesne,Meredith McKean,Michael J. Wagner,Silvia Stacchiotti,Samuel Agresta,Alfonso Quintás-Cardama,Sarah A. Reilly,Kathleen Healy,Denice Hickman,Tina Zhao,Alex Ballesteros‐Perez,Alexis Khalil,Michael P. Collins,Jessica Piel
标识
DOI:10.1158/1078-0432.ccr-24-2583
摘要
FHD-609, a potent, selective, heterobifunctional degrader of bromodomain-containing protein 9 (BRD9), was evaluated for treatment of patients with advanced synovial sarcoma (SS) or SMARCB1-deficient tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI